Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q D Nguyen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Investigative Ophthalmology & Visual Science|October 3, 2001
Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitisQ D Nguyen, H S Uy, A Merchant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathwaysS Rodrigues, Q D Nguyen, S Faivre, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Eye (London, England)|August 9, 2014
Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivityE Hatef, M Hanout, A Moradi, et al.
Eye (London, England)|December 3, 2011
Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edemaM A Ibrahim, Y J Sepah, R C A Symons, et al.
Oncogene|September 1, 2009
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell deathD A Tennant, C Frezza, E D MacKenzie, et al.
Eye (London, England)|August 1, 2015
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)D V Do, Y J Sepah, D Boyer, et al.
Eye (London, England)|August 23, 2014
Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumabA Moradi, Y J Sepah, M A Ibrahim, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
Eye (London, England)|May 26, 2012
Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patientsQ D Nguyen, R A Schachar, C I Nduaka, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Investigative Ophthalmology & Visual Science|October 3, 2001
Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitisQ D Nguyen, H S Uy, A Merchant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathwaysS Rodrigues, Q D Nguyen, S Faivre, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Eye (London, England)|August 9, 2014
Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivityE Hatef, M Hanout, A Moradi, et al.
Eye (London, England)|December 3, 2011
Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edemaM A Ibrahim, Y J Sepah, R C A Symons, et al.
Oncogene|September 1, 2009
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell deathD A Tennant, C Frezza, E D MacKenzie, et al.
Eye (London, England)|August 1, 2015
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)D V Do, Y J Sepah, D Boyer, et al.
Eye (London, England)|August 23, 2014
Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumabA Moradi, Y J Sepah, M A Ibrahim, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
Eye (London, England)|May 26, 2012
Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patientsQ D Nguyen, R A Schachar, C I Nduaka, et al.
Pageof 6